365 related articles for article (PubMed ID: 23737997)
1. Intermedin suppresses pressure overload cardiac hypertrophy through activation of autophagy.
Chen H; Wang X; Tong M; Wu D; Wu S; Chen J; Wang X; Wang X; Kang Y; Tang H; Tang C; Jiang W
PLoS One; 2013; 8(5):e64757. PubMed ID: 23737997
[TBL] [Abstract][Full Text] [Related]
2. Intermedin alleviates pathological cardiac remodeling by upregulating klotho.
Zhang LS; Liu Y; Chen Y; Ren JL; Zhang YR; Yu YR; Jia MZ; Ning ZP; Du J; Tang CS; Qi YF
Pharmacol Res; 2020 Sep; 159():104926. PubMed ID: 32502636
[TBL] [Abstract][Full Text] [Related]
3. Influence of atenolol and nifedipine on nitric-oxide deficient cardiomyocyte hypertrophy and expression of the cardio-endocrine peptide intermedin and its receptor components.
Bell D; Zhao YY; Devine AB; McDermott BJ
Cell Physiol Biochem; 2008; 21(1-3):203-14. PubMed ID: 18209487
[TBL] [Abstract][Full Text] [Related]
4. Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy.
Li MH; Zhang YJ; Yu YH; Yang SH; Iqbal J; Mi QY; Li B; Wang ZM; Mao WX; Xie HG; Chen SL
Eur J Pharmacol; 2014 Apr; 728():67-76. PubMed ID: 24508518
[TBL] [Abstract][Full Text] [Related]
5. Protective Roles of Interferon-γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload.
Kimura A; Ishida Y; Furuta M; Nosaka M; Kuninaka Y; Taruya A; Mukaida N; Kondo T
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29555642
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of an anti-oxidant intervention on cardiomyocyte expression of adrenomedullin and intermedin and their receptor components in chronic nitric oxide deficiency.
Bell D; Zhao Y; McCoy FP; Devine AB; McDermott BJ
Cell Physiol Biochem; 2007; 20(5):269-82. PubMed ID: 17762156
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
[TBL] [Abstract][Full Text] [Related]
8. Secretoneurin suppresses cardiac hypertrophy through suppression of oxidant stress.
Chen HL; Liu Y; Jiang W; Wang XX; Yuan GL; Zhao YL; Yu C
Eur J Pharmacol; 2018 Mar; 822():13-24. PubMed ID: 29337195
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension.
Zhao Y; Bell D; Smith LR; Zhao L; Devine AB; McHenry EM; Nicholls DP; McDermott BJ
J Pharmacol Exp Ther; 2006 Mar; 316(3):1269-81. PubMed ID: 16326922
[TBL] [Abstract][Full Text] [Related]
10. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
[TBL] [Abstract][Full Text] [Related]
11. Expression of the counter-regulatory peptide intermedin is augmented in the presence of oxidative stress in hypertrophied cardiomyocytes.
Bell D; Zhao Y; McCoy FP; Devine A; McDermott BJ
Cell Physiol Biochem; 2008; 21(5-6):409-20. PubMed ID: 18453748
[TBL] [Abstract][Full Text] [Related]
12. Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis.
Podesser BK; Kreibich M; Dzilic E; Santer D; Förster L; Trojanek S; Abraham D; Krššák M; Klein KU; Tretter EV; Kaun C; Wojta J; Kapeller B; Gonçalves IF; Trescher K; Kiss A
J Hypertens; 2018 Apr; 36(4):847-856. PubMed ID: 29283973
[TBL] [Abstract][Full Text] [Related]
13. Effect of intermedin1-53 on angiotensin II-induced hypertrophy in neonatal rat ventricular myocytes.
Yang JH; Ma CG; Cai Y; Pan CS; Zhao J; Tang CS; Qi YF
J Cardiovasc Pharmacol; 2010 Jul; 56(1):45-52. PubMed ID: 20351561
[TBL] [Abstract][Full Text] [Related]
14. Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway.
Li RL; Wu SS; Wu Y; Wang XX; Chen HY; Xin JJ; Li H; Lan J; Xue KY; Li X; Zhuo CL; Cai YY; He JH; Zhang HY; Tang CS; Wang W; Jiang W
J Mol Cell Cardiol; 2018 Aug; 121():242-255. PubMed ID: 30053525
[TBL] [Abstract][Full Text] [Related]
15. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
[TBL] [Abstract][Full Text] [Related]
16. Intermedin1-53 protects against cardiac hypertrophy by inhibiting endoplasmic reticulum stress via activating AMP-activated protein kinase.
Lu WW; Zhao L; Zhang JS; Hou YL; Yu YR; Jia MZ; Tang CS; Qi YF
J Hypertens; 2015 Aug; 33(8):1676-87. PubMed ID: 26136070
[TBL] [Abstract][Full Text] [Related]
17. Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction.
Zhao L; Cheng G; Jin R; Afzal MR; Samanta A; Xuan YT; Girgis M; Elias HK; Zhu Y; Davani A; Yang Y; Chen X; Ye S; Wang OL; Chen L; Hauptman J; Vincent RJ; Dawn B
Circ Res; 2016 Jun; 118(12):1918-1929. PubMed ID: 27126808
[TBL] [Abstract][Full Text] [Related]
18. C-C chemokine receptor 5 signaling contributes to cardiac remodeling and dysfunction under pressure overload.
Wang X; Li W; Yue Q; Du W; Li Y; Liu F; Yang L; Xu L; Zhao R; Hu J
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200795
[TBL] [Abstract][Full Text] [Related]
19. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
Zhou N; Ma B; Stoll S; Hays TT; Qiu H
Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-(3-7) alleviates isoprenaline-induced cardiac remodeling via attenuating cAMP-PKA and PI3K/Akt signaling pathways.
Zhang Y; Shang Z; Liu A
Amino Acids; 2021 Oct; 53(10):1533-1543. PubMed ID: 34494132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
